NDC 69097-421-19 - CELECOXIB
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69097-421
- Requested NDC
- 69097-421-19
- Package NDCs from labels
- 69097-421-07, 69097-421-12, 69097-421-02, 69097-421-19, 69097-421-21
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-07-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CELECOXIB - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-07-21 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - Medsource Pharmaceuticals | Cipla Limited- Kurkumbh | Medsource Pharmaceuticals | Cipla Limited- Kurkumbh | 2026-05-20 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - PD-Rx Pharmaceuticals, Inc. | PD-Rx Pharmaceuticals, Inc. | 2025-04-11 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - Cipla USA Inc. | CIPLA LIMITED KURKUMBH | CIPLA LIMITED INDORE | Cipla USA Inc. | CIPLA LIMITED KURKUMBH | CIPLA LIMITED INDORE | 2025-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2023-01-03 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - RedPharm Drug, Inc. | RedPharm Drug, Inc. | 2022-01-21 | HUMAN PRESCRIPTION DRUG LABEL |
| CELECOXIB - A-S Medication Solutions | A-S Medication Solutions | 2018-01-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69097-421-02 | CELECOXIB | 30 in 1 BOTTLE | CAPSULE | 30 | 14 | |
| 69097-421-07 | CELECOXIB | 100 in 1 BOTTLE | CAPSULE | 100 | 14 | |
| 69097-421-12 | CELECOXIB | 500 in 1 BOTTLE | CAPSULE | 500 | 14 | |
| 69097-421-19 | CELECOXIB | 10 in 1 BLISTER PACK | CAPSULE | 10 | 14 | |
| 69097-421-21 | CELECOXIB | 10 in 1 CARTON | CAPSULE | 10 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69097-421-07 | EA - Each | 69097-421 | c42aa30f-1dee-4eb3-bad6-220ead35de27 | 1 | 2016-04-04 |
| 69097-421-12 | EA - Each | 69097-421 | bb14d7e3-0d91-4d55-bc43-e2db9461b9e7 | 1 | 2016-04-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| Celecoxib | CELECOXIB | Alembic Pharmaceuticals Limited | 14e8d788-e44c-4a40-8678-25cf45fed477 | 2025-09-18 | Boxed warning, Warnings, Adverse reactions | 686379 205323 349514 205322 JCX84Q7J1L |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
| CELECOXIB | CELECOXIB | PHOENIX RX LLC | 3a669c28-fbc7-827c-e063-6394a90a0829 | 2025-08-03 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| VYSCOXA | CELECOXIB | Carwin Pharmaceutical Associates, LLC | 5094d47e-f791-4190-9397-b7500143a74d | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | PHOENIX RX LLC | 3a7b127e-c919-418f-e063-6394a90a06d0 | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Proficient Rx LP | 3a450db8-313c-4120-9b8e-58c956323fa4 | 2025-06-01 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | A-S Medication Solutions | 95b2ced1-eca2-4c25-aa10-c9fb86b353a3 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | ANDA207446 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | A-S Medication Solutions | 7b8e923c-253f-461e-94d7-669e75dc73e9 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | ANDA207446 205323 JCX84Q7J1L |
| celecoxib | CELECOXIB | Bryant Ranch Prepack | 351f5f07-bdd4-9893-e063-6394a90a7281 | 2025-05-14 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Micro Labs Limited | 408b30d6-f5c2-4239-b993-d8f77a8e160b | 2025-05-13 | Boxed warning, Warnings, Adverse reactions | 686379 205323 349514 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Asclemed USA, Inc. | 5d0dcac1-237c-47aa-bcfb-50fa20b5b838 | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | 686379 205323 349514 205322 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | PD-Rx Pharmaceuticals, Inc. | 3191c9dc-bfdf-0591-e054-00144ff8d46c | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | ANDA207446 43063-669-20 43063-669-14 43063-669-30 43063-669-60 43063-669-10 43063-669 205323 3284fb4d-544b-d0dc-e063-6394a90a8af4 3191c9dc-bfdf-0591-e054-00144ff8d46c JCX84Q7J1L |
| celecoxib | CELECOXIB | RedPharm Drug, Inc. | 50c29846-3426-0310-e054-00144ff8d46c | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Quallent Pharmaceuticals Health LLC | aaa3a4f5-b281-415f-a08c-e0cefdae2fb5 | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | ANDA207446 205323 205322 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Cipla USA Inc. | d12625b1-2af9-4532-af91-d40b65eeffef | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | ANDA207446 69097-422-07 69097-422-21 69097-420-02 69097-420-03 69097-420-11 69097-421-21 69097-423-03 69097-422-19 69097-420-19 69097-421-07 69097-421-19 69097-423-02 69097-421-02 69097-422-12 69097-420-21 69097-421-12 69097-422-02 69097-422 69097-423 69097-421 69097-420 69097042119 686379 205323 349514 205322 8df39b9c-af70-4ac3-ba9f-6e8e795ba961 d12625b1-2af9-4532-af91-d40b65eeffef JCX84Q7J1L |
| CELECOXIB | CELECOXIB | NorthStar RxLLC | ce61a585-5ac0-4185-99eb-a9511cd25a98 | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | ANDA207446 686379 205323 349514 205322 JCX84Q7J1L |
| celecoxib | CELECOXIB | Bryant Ranch Prepack | ac5c0d72-1bb3-4065-b2f4-5516b0869775 | 2025-02-20 | Boxed warning, Warnings, Adverse reactions | 205323 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | NCS HealthCare of KY, LLC dba Vangard Labs | 34bef49c-eca1-4f17-9b1b-55900ac40829 | 2025-02-20 | Boxed warning, Warnings, Adverse reactions | 205323 205322 JCX84Q7J1L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.